基本信息
views: 264
Career Trajectory
Bio
Recent projects
Study on new treatment options for irritable bowel syndrome (02/01/2023 - 02/01/2027) - Promotor
Multicenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndrome (01/10/2022 - 30/09/2026) - Promotor
Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometry (01/05/2022 - 30/04/2026) - Co-promotor
Identification of the mast cell-related immune mechanisms underlying the development of visceral pain in irritable bowel syndrome (14/03/2022 - 14/03/2026) - Promotor
Characterization of the early immune events underlying food-induced abdominal pain (01/01/2022 - 31/12/2025) - Promotor
GPR18 as novel target to treat visceral pain (01/10/2021 - 30/09/2022) - Promotor
Immunological memory of the macrophage niche (MacNicheMemo) (15/09/2021 - 13/07/2025) - Promotor
Understanding inherited and acquired genetic variation in Parkinson's disease through single-cell multi-omics analyses: a unique data resource (01/03/2021 - 29/02/2024) - Co-promotor
Understanding inherited and acquired genetic variation in Parkinson's disease through single-cell multi-omics analysis: a unique data resource. (01/03/2021 - 29/02/2024) - Co-promotor
Immunological memory of the macrophage niche (MacNicheMemo). (01/01/2021 - 31/12/2024) - Promotor
Study on new treatment options for irritable bowel syndrome (02/01/2023 - 02/01/2027) - Promotor
Multicenter randomized controlled clinical trial comparing ebastine and mebeverine as treatment of irritable bowel syndrome (01/10/2022 - 30/09/2026) - Promotor
Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometry (01/05/2022 - 30/04/2026) - Co-promotor
Identification of the mast cell-related immune mechanisms underlying the development of visceral pain in irritable bowel syndrome (14/03/2022 - 14/03/2026) - Promotor
Characterization of the early immune events underlying food-induced abdominal pain (01/01/2022 - 31/12/2025) - Promotor
GPR18 as novel target to treat visceral pain (01/10/2021 - 30/09/2022) - Promotor
Immunological memory of the macrophage niche (MacNicheMemo) (15/09/2021 - 13/07/2025) - Promotor
Understanding inherited and acquired genetic variation in Parkinson's disease through single-cell multi-omics analyses: a unique data resource (01/03/2021 - 29/02/2024) - Co-promotor
Understanding inherited and acquired genetic variation in Parkinson's disease through single-cell multi-omics analysis: a unique data resource. (01/03/2021 - 29/02/2024) - Co-promotor
Immunological memory of the macrophage niche (MacNicheMemo). (01/01/2021 - 31/12/2024) - Promotor
Research Interests
Papers共 371 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hind Hussein,Elodie Modave, Samuel Van Remoortel,Marcello Delfini, Runze Quan,Nathalie Stakenborg,Guy Boeckxstaens
Gastroenterologyno. 5 (2024): S-192
K. Hugova, J. Mares, B. Hakanson, A. Repici,B.H. A. Von Rahden, A. Bredenoord,R. Bisschops,H. Messmann, M. C. Vollberg, T. Ruppenthal, O. Mann,J. Izbicki,
ESGE Days 2024 Endoscopy (2024)
Gastroenterologyno. 5 (2024): S-980-S-981
Guy Boeckxstaens,Sabry Ayad,George Dukes,Michael Essandoh, Ryan Gryder, Pravin Kamble, Jason Tackett, Paresh Thakker,James Williams, Yanwei Zhang, Paul R. Wade
GUTno. 3 (2024): 459-469
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Societyno. 2 (2023)
M. Cuende-Estevez, L. Decraecker, R. Quan,A. Denadai-Souza,M. F. Viola, J. Aguilera-Lizarraga,N. Stakenborg,H. Hussein,G. Boeckxstaens
NEUROGASTROENTEROLOGY AND MOTILITY (2023)
Cited0Views0Bibtex
0
0
Thomas Plum, Rebecca Binzberger,Robin Thiele,Fuwei Shang,Daniel Postrach,Candice Fung,Marina Fortea,Nathalie Stakenborg, Zheng Wang,Anke Tappe-Theodor,Tanja Poth, Duncan A. A. MacLaren,
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn